Twist Bioscience Corp 2021 SR
The report highlights Twist Bioscience's commitment to sustainability through its proprietary silicon-based DNA synthesis platform, which reduces chemical reagent use and waste by 99.8%. The company emphasizes its diverse workforce, with women representing 42% of the executive team and 30% of the Board of Directors. Key environmental initiatives include a laboratory glove recycling program that has diverted over 11,700 pounds of plastic from landfills. Additionally, the report details the company's rigorous biosecurity program and its contributions to global health, particularly in developing tools to combat COVID-19.
Company: Twist Bioscience Corp
Sector: Health Care
Country: United States
Year: 2021
Type: SR
Pages: 52
Twist Bioscience Corp
ESG Report
The report highlights Twist Bioscience's commitment to sustainability through its proprietary silicon-based DNA synthesis platform, which reduces chemical reagent use and waste by 99.8%. The company emphasizes its diverse workforce, with women representing 42% of the executive team and 30% of the Board of Directors. Key environmental initiatives include a laboratory glove recycling program that has diverted over 11,700 pounds of plastic from landfills. Additionally, the report details the company's rigorous biosecurity program and its contributions to global health, particularly in developing tools to combat COVID-19.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Oct 1, 2020 - Sep 30, 2021
Fiscal Year
2021
Published
Jan 1, 2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Workplace Fatalities
Employees